1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Interventional Oncology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Interventional Oncology Market, by Techniques
8.1.1. Ablation Therapies
8.1.1.1. Market Revenue and Forecast
8.1.2. Embolization Therapies
8.1.2.1. Market Revenue and Forecast
8.1.3. Biopsy Techniques
8.1.3.1. Market Revenue and Forecast
8.1.4. Targeted Therapy Delivery Systems
8.1.4.1. Market Revenue and Forecast
8.1.5. Image-Guided Procedures
8.1.5.1. Market Revenue and Forecast
9.1. Interventional Oncology Market, by Procedure
9.1.1. Tumor Ablation
9.1.1.1. Market Revenue and Forecast
9.1.2. Tumor Biopsy
9.1.2.1. Market Revenue and Forecast
9.1.3. Vascular Interventions
9.1.3.1. Market Revenue and Forecast
9.1.4. Palliative Care
9.1.4.1. Market Revenue and Forecast
10.1. Interventional Oncology Market, by Application
10.1.1. Liver Cancer
10.1.1.1. Market Revenue and Forecast
10.1.2. Lung Cancer
10.1.2.1. Market Revenue and Forecast
10.1.3. Kidney Cancer
10.1.3.1. Market Revenue and Forecast
10.1.4. Prostate Cancer
10.1.4.1. Market Revenue and Forecast
10.1.5. Breast Cancer
10.1.5.1. Market Revenue and Forecast
11.1. Interventional Oncology Market, by End-user
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Specialty Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Techniques
12.1.2. Market Revenue and Forecast, by Procedure
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End-user
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Techniques
12.1.5.2. Market Revenue and Forecast, by Procedure
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End-user
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Techniques
12.1.6.2. Market Revenue and Forecast, by Procedure
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End-user
12.2. Europe
12.2.1. Market Revenue and Forecast, by Techniques
12.2.2. Market Revenue and Forecast, by Procedure
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-user
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Techniques
12.2.5.2. Market Revenue and Forecast, by Procedure
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End-user
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Techniques
12.2.6.2. Market Revenue and Forecast, by Procedure
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End-user
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Techniques
12.2.7.2. Market Revenue and Forecast, by Procedure
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End-user
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Techniques
12.2.8.2. Market Revenue and Forecast, by Procedure
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End-user
12.3. APAC
12.3.1. Market Revenue and Forecast, by Techniques
12.3.2. Market Revenue and Forecast, by Procedure
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End-user
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Techniques
12.3.5.2. Market Revenue and Forecast, by Procedure
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End-user
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Techniques
12.3.6.2. Market Revenue and Forecast, by Procedure
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End-user
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Techniques
12.3.7.2. Market Revenue and Forecast, by Procedure
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End-user
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Techniques
12.3.8.2. Market Revenue and Forecast, by Procedure
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End-user
12.4. MEA
12.4.1. Market Revenue and Forecast, by Techniques
12.4.2. Market Revenue and Forecast, by Procedure
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End-user
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Techniques
12.4.5.2. Market Revenue and Forecast, by Procedure
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End-user
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Techniques
12.4.6.2. Market Revenue and Forecast, by Procedure
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End-user
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Techniques
12.4.7.2. Market Revenue and Forecast, by Procedure
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End-user
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Techniques
12.4.8.2. Market Revenue and Forecast, by Procedure
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End-user
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Techniques
12.5.2. Market Revenue and Forecast, by Procedure
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End-user
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Techniques
12.5.5.2. Market Revenue and Forecast, by Procedure
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End-user
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Techniques
12.5.6.2. Market Revenue and Forecast, by Procedure
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End-user
13.1. Medtronic plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Boston Scientific Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Johnson & Johnson (Ethicon)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Teleflex Incorporated
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Cook Medical
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. AngioDynamics Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Stryker Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Profound Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Terumo Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Siemens Healthineers
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
